FAIRBAIRN EMILY
Transaction: 05/27/2026
SELL
Change
-724,637
Price
Not reported
Filing
05/29/2026
Type
SELL
IN8bio, Inc.
INAB • Biotechnology
$1.20
▲ +0.04 (+3.45%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$23.01M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.1Healthy liquidity · 8.82Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:47 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.20
Change3.45%
Shares Out19.47M
Market Cap$23.01M
Enterprise Value$7.23M
52W Range0.90 - 2.73
Beta0.28
P/E-1.23
P/B1.25
P/FCF-1.58
EV/EBITDA-0.42
EV/FCF-0.50
Price$1.20
Change3.45%
Shares Out19.47M
Market Cap$23.01M
Enterprise Value$7.23M
52W Range0.90 - 2.73
Beta0.28
P/E-1.23
P/B1.25
P/FCF-1.58
EV/EBITDA-0.42
EV/FCF-0.50
Earnings Yield-81.13%
FCF Yield-63.44%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.10
Current Ratio8.82
Quick Ratio8.82
Target$4.00
Target Upside233.33%
Target Median$4.00
Target Range4.00 - 4.00
Volume717.00
Avg Volume56.92K
EPS Surprise0.33
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.1Healthy liquidity · 8.82Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-04
88/100
Bullish
Bullish
3
Hold
1
Bearish
0
Price Target
2026-08-07
Low
$4.00
Mean
$4.00
Median
$4.00
High
$4.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Graff Jeremy R.
Transaction: 05/09/2026
BUY
Change
+22,000
Price
$1.58
Filing
05/12/2026
Type
BUY
Brandt Peter C.
Transaction: 05/09/2026
BUY
Change
+22,000
Price
$1.58
Filing
05/12/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| FAIRBAIRN EMILY | SELL | -724,637 | Not reported | 05/27/2026 | 05/29/2026 |
| Graff Jeremy R. | BUY | +22,000 | $1.58 | 05/09/2026 | 05/12/2026 |
| Brandt Peter C. | BUY | +22,000 | $1.58 | 05/09/2026 | 05/12/2026 |
| Epperly Corinne | BUY | +22,000 | $1.58 | 05/09/2026 | 05/12/2026 |
| Rochlin Kate | BUY | +60,000 | $1.58 | 05/09/2026 | 05/12/2026 |
| McCall Patrick | BUY | +56,250 | $1.58 | 05/09/2026 | 05/12/2026 |
| FAIRBAIRN EMILY | BUY | +22,000 | $1.58 | 05/09/2026 | 05/12/2026 |
| Lamb Lawrence | BUY | +54,000 | $1.58 | 05/09/2026 | 05/12/2026 |
| Greenwood Luba | BUY | +22,000 | $1.58 | 05/09/2026 | 05/12/2026 |
| Ho William Tai-Wei | BUY | +154,500 | $1.58 | 05/09/2026 | 05/12/2026 |
| Ho William Tai-Wei | BUY | +206,000 | $1.96 | 02/04/2026 | 02/06/2026 |
| Rochlin Kate | BUY | +80,000 | $1.96 | 02/04/2026 | 02/06/2026 |
| McCall Patrick | BUY | +75,000 | $1.96 | 02/04/2026 | 02/06/2026 |
| Lamb Lawrence | BUY | +72,000 | $1.96 | 02/04/2026 | 02/06/2026 |
| FAIRBAIRN EMILY | BUY | +724,637 | $1.38 | 12/22/2025 | 12/23/2025 |
| Brandt Peter C. | BUY | +72,464 | $1.38 | 12/22/2025 | 12/23/2025 |
| Roemer Alan S. | BUY | +36,232 | $1.38 | 12/22/2025 | 12/23/2025 |
| Ho William Tai-Wei | BUY | +36,232 | $1.38 | 12/22/2025 | 12/23/2025 |
| McCall Patrick | BUY | +7,247 | $1.38 | 12/22/2025 | 12/23/2025 |
| Rochlin Kate | BUY | +7,247 | $1.38 | 12/22/2025 | 12/23/2025 |